PUMA BIOTECHNOLOGY, INC.: cash_and_equivalents
| Value | {"amount": 31569000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2015-12-31) |
| Status | current |
| Entity | PUMA BIOTECHNOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:37:32.067047+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1d48ee20-c0b7-4024-be2c-8cff014e7ccb
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-16-013716Retrieved: 2026-08-19T13:37:32.067047+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001401667/cash-and-equivalents/2015-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1d48ee20-c0b7-4024-be2c-8cff014e7ccb
History
- no predecessors — first report